- Exchange: Venture
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Welichem Biotech Inc
+ Add to WatchlistWBI:CN
0.1300 CAD 0.00000.00%As of 12:16:55 ET on 04/22/2013.
Snapshot for Welichem Biotech Inc (WBI)
| Open: | - | Day's Range: | - | Volume: | 500 |
|---|---|---|---|---|---|
| Previous Close: | 0.1300 | 52wk Range: | 0.0700 - 0.4800 | 1-Yr Rtn: | - |
Key Statistics for WBI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPTSX | - |
| Earnings Per Share (ttm) | 0.0000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M CAD) | 10.24 |
| Shares Outstanding (M) | 78.79 |
| 30 Day Average Volume | 526 |
| Price/Book (mrq) | 0.2820 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/11/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for WBI
Company Profile & Key Executives for WBI
Welichem Biotech, Inc. is a biotechnology company. The Company researches therapies for autoimmune and inflammatory diseases.
| John M WebsterChairman/Chief Scientific Ofcr | Liren TangPresident/CEO |
| Harvey QuanCFO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
WBI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page